NCT00772499 - Vascular Improvement With Olmesartan Medoxomil Study | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Hypertension

Interventions

DRUG

olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure

Tablets and capsules for oral administration once or twice daily for up to 52 weeks

DRUG

atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure

Tablets and capsules for oral administration once or twice daily for up to 52 weeks

Trial Locations (1)

Wake Forest University Baptist Medical Center, Winston-Salem